Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | USP2 | O75604 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.42 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.39 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5955831 | 1.00 | CA2 (0.57) | CA2MAPK1MAPTABCC4TSHR | |
| SCHEMBL5955875 | 1.00 | CA2 (0.57) | CA2MAPK1MAPTABCC4TSHR | |
| SCHEMBL2284656 | 1.00 | CA2 (0.57) | CA2MAPK1MAPTABCC4TSHR | |
| SCHEMBL1024655 | 1.00 | CA2 (0.57) | CA2MAPK1MAPTABCC4TSHR | |
| SCHEMBL3125190 | 0.98 | CA2 (0.59) | CA2MAPK1MAPTABCC4TSHR | |
| SCHEMBL3111645 | 0.92 | CA2 (0.61) | CA2MAPK1MAPTABCC4TSHR | |
| Undecylenic Acid SCHEMBL30295604 | 0.92 | MAPT (0.62) | CA2MAPK1MAPTABCC4ALDH1A1 | |
| SCHEMBL29022326 | 0.91 | CA2 (0.56) | CA2MAPK1MAPTABCC4TSHR | |
| SCHEMBL4015850 | 0.88 | MAPT (0.54) | CA2MAPK1MAPTABCC4TSHR | |
| SCHEMBL21439803 | 0.88 | MAPT (0.54) | CA2MAPK1MAPTABCC4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795124-B2 | Renewable alkene production engaging metathesis | NESTE OYJ (FI) | 2023-10-24 | — | — | US | claimed |
| US-11643616-B2 | Renewable base oil production engaging metathesis | NESTE OYJ (FI) | 2023-05-09 | — | — | US | claimed |
| US-20220363613-A1 | RENEWABLE ALKENE PRODUCTION ENGAGING METATHESIS | NESTE OYJ (FI) | 2022-11-17 | — | — | US | claimed |
| US-20220340835-A1 | RENEWABLE BASE OIL PRODUCTION ENGAGING METATHESIS | NESTE OYJ (FI) | 2022-10-27 | — | — | US | claimed |
| EP-4034522-A1 | RENEWABLE ALKENE PRODUCTION ENGAGING METATHESIS | Neste Oyj (FI) | 2022-08-03 | — | — | EP | claimed |
| EP-4034613-A1 | RENEWABLE BASE OIL PRODUCTION ENGAGING METATHESIS | Neste Oyj (FI) | 2022-08-03 | — | — | EP | claimed |
| WO-2021058875-A1 | RENEWABLE BASE OIL PRODUCTION ENGAGING METATHESIS | NESTE OYJ (FI) | 2021-04-01 | — | — | WO | claimed |
| WO-2021058876-A1 | RENEWABLE ALKENE PRODUCTION ENGAGING METATHESIS | NESTE OYJ (FI) | 2021-04-01 | — | — | WO | claimed |
| US-20200093181-A1 | FLAVORANTS | RAI STRATEGIC HOLDINGS, INC. | 2020-03-26 | — | — | US | claimed |
| WO-2020058881-A1 | FLAVORANTS FOR SMOKING ARTICLES | RAI STRATEGIC HOLDINGS, INC. (US) | 2020-03-26 | — | — | WO | claimed |
| US-9346729-B2 | Methods of converting mixtures of palmitoleic and oleic acid esters to high value products | HELIAE DEVELOPMENT, LLC (US) | 2016-05-24 | — | — | US | claimed |
| US-20150344401-A1 | METHODS OF CONVERTING MIXTURES OF PALMITOLEIC AND OLEIC ACID ESTERS TO HIGH VALUE PRODUCTS | HELIAE DEVELOPMENT LLC | 2015-12-03 | — | — | US | claimed |
| US-20250034493-A1 | RUM REPLICAS | AVA FOOD LABS, INC. | 2025-01-30 | — | — | US | disclosed |
| US-12145906-B2 | Renewable chemical production engaging metathesis and microbial oxidation | NESTE OYJ (FI) | 2024-11-19 | — | — | US | disclosed |
| EP-4430155-A1 | RUM REPLICAS | AVA FOOD LABS, INC. (US) | 2024-09-18 | — | — | EP | disclosed |
| US-11958042-B2 | Reactions of olefin derivatives in the presence of metathesis catalysts | UMICORE AG & CO. KG (DE) | 2024-04-16 | — | — | US | disclosed |
| US-20040122192-A1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. | 2004-06-24 | — | — | US | disclosed |
| WO-2003093215-A1 | INTERGRATED CHEMICAL PROCESSES FOR INDUSTRIAL UTILIZATION OF SEED OILS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2003-11-13 | — | — | WO | disclosed |
| US-20020156207-A1 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof | MITSUI CHEMICALS, INC. (JP) | 2002-10-24 | — | — | US | disclosed |
| EP-1186619-A2 | Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition contaning the copolymer, and uses thereof | Mitsui Chemicals, Inc. (JP) | 2002-03-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12145906-B2 | Renewable chemical production engaging metathesis and microbial oxidation | FASN, MLYCD, COASY | CA2 750/4885MAPK1 1255/4885MAPT 2154/4885 |
| US-20220340835-A1 | RENEWABLE BASE OIL PRODUCTION ENGAGING METATHESIS | FASN, DGAT2, GK | CA2 2618/4885MAPK1 2207/4885MAPT 3202/4885 |
| US-20220363613-A1 | RENEWABLE ALKENE PRODUCTION ENGAGING METATHESIS | FASN, DGAT2, DGAT1 | CA2 3305/4885MAPK1 2562/4885MAPT 3375/4885 |
| US-20150344401-A1 | METHODS OF CONVERTING MIXTURES OF PALMITOLEIC AND OLEIC ACID ESTERS TO HIGH VALUE PRODUCTS | COASY, FASN, FADS1 | CA2 1342/4885MAPK1 4550/4885MAPT 3232/4885 |
| US-11958042-B2 | Reactions of olefin derivatives in the presence of metathesis catalysts | SYMPK, MDK, HCK | CA2 4518/4885MAPK1 2732/4885MAPT 1776/4885 |
| US-11643616-B2 | Renewable base oil production engaging metathesis | FASN, DGAT2, GK | CA2 2618/4885MAPK1 2207/4885MAPT 3202/4885 |
| US-11795124-B2 | Renewable alkene production engaging metathesis | FASN, DGAT2, DGAT1 | CA2 3305/4885MAPK1 2562/4885MAPT 3375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.